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Background
A cross-over design is contraindicated in trials of inter-
ventions with curative or deep-rooted effects, which are
not washed out in participants randomised to receive the
control after the experimental intervention. A parallel
groups design with or without a baseline assessment of
outcome is commonly employed instead. We focus here
on the situation where the control is routine care, or
where the experimental intervention is the control plus
something else, so that wash-out in participants moving
from the control to the experimental arm is not an issue.
Methods
We describe a simple but novel alternative design and
its performance characteristics. One group is assessed
before and after the experimental intervention, while
two further, independent groups provide treatment
comparisons at each time point. We call this a dog-leg
design because of the pattern of assessments in the
three groups.
Results
If the correlation between baseline and follow-up is
<0.72, the dog-leg design requires fewer participants
than a parallel groups design with baseline assessment
(i.e. an ANCOVA design) to achieve the same power.
The dog-leg design also requires fewer assessments in
total than a parallel groups design where participants
are only assessed once, at follow-up.
Conclusions
The dog-leg design is reminiscent of a stepped-wedge
design, but with a reduced schedule of assessments, and
with the notable difference that not all groups receive
the intervention. There is a risk of differential attrition
in the three arms, but the design’s good performance
relative to alternatives make it an attractive addition to
the methodologist’s toolkit.
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